Modifié le
New ANR granted: ReBoRN project
The French National Agency for Research (ANR) has awarded funding to the ReBoRN project, coordinated by Sophie Hillion.
Modifié le
Some news from the SIGNATURE EU Doctoral Network
The SIGNATURE doctoral network is issuing its first newsletter
Modifié le
A study to assess the efficacy and safety of dazodalibep in Sjögren's disease
A study to assess the efficacy and safety of the CD40 ligand antagonist dazodalibep in Sjögren's disease
Modifié le
📣 10 Open Positions for different locations for the European project SIGNATURE!
The Doctoral Network SIGNATURE is hiring 10 PhD candidates in Europe
Modifié le
New article in Nature Review in Rheumatology
Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases
Modifié le
15th International Symposium on Sjögren's Syndrome
The 15th international symposium on Sjögren's Syndrome will take place in Rome from 7 to 10 September 2022.
Modifié le
New study to investigate ianalumab and its mechanism of efficacy in Sjögren's patients
New study to investigate the ianalumab monoclonal antibody and its mechanism of efficacy in Sjögren's patients
Modifié le
Transfer Technology Prize: Olivier Mignen and his group awarded
Dr. Olivier Mignen and his team have been awarded the prize of 'Transfer of Technology' by Ouest Valorisation.